Advertisement

U.S. markets closed

S&P 500
4,288.05
-11.65(-0.27%)
Dow 30
33,507.50
-158.84(-0.47%)
Nasdaq
13,219.32
+18.05(+0.14%)
Russell 2000
1,785.10
-9.21(-0.51%)
Crude Oil
90.77
-0.94(-1.02%)
Gold
1,864.60
-14.00(-0.75%)

Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD

Visitors trend2W10W9M

33.17

+1.08

(+3.37%)

At close: 04:02PM EDT

33.17

0.00

(0.00%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Relative Strength Index (RSI)

View all chart patterns

Performance Outlook

Previous Close	32.09
Open	32.35
Bid	33.13 x 27000
Ask	33.25 x 3000
Day's Range	32.30 - 33.23
52 Week Range	31.77 - 54.93
Volume	42,349,800
Avg. Volume	24,336,795

Market Cap	187.276B
Beta (5Y Monthly)	0.55
PE Ratio (TTM)	8.82
EPS (TTM)	3.76
Earnings Date	Oct 31, 2023
Forward Dividend & Yield	1.64 (4.94%)
Ex-Dividend Date	Jul 27, 2023
1y Target Est	44.38

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Pfizer, Inc.
Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Rating
Fair Value
Economic Moat
4 days agoMorningstar

All

Motley Fool
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
BioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts' price target reflects an upside potential of 56%. Granted, not every analyst is all that bullish about BioNTech.
Motley Fool
Could Viatris Stock Help You Become a Millionaire?
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.

Advertisement

S&P 5004,288.05-11.65(-0.27%)

Dow 3033,507.50-158.84(-0.47%)

Nasdaq13,219.32+18.05(+0.14%)

Russell 20001,785.10-9.21(-0.51%)

Crude Oil90.77-0.94(-1.02%)

Gold1,864.60-14.00(-0.75%)

Pfizer Inc. (PFE)

Chart Events

Performance Outlook

Fair Value

Related Research

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

Could Viatris Stock Help You Become a Millionaire?

Moderna's Shares Could Take Off if These 2 Things Happen

S&P 500
4,288.05
-11.65(-0.27%)

Dow 30
33,507.50
-158.84(-0.47%)

Nasdaq
13,219.32
+18.05(+0.14%)

Russell 2000
1,785.10
-9.21(-0.51%)

Crude Oil
90.77
-0.94(-1.02%)

Gold
1,864.60
-14.00(-0.75%)